Popular Searches:

Your Previous Searches:

Recently Visited Pages:

Home
Equities
Equities
View All Equities
Equities by Sector

Consumer

Financials

Healthcare

Industrials

Investment Companies

Metals & Mining

Oil & Gas

Real Estate

TMT

MagForce

MCap

—

Last close

-0.02

▲ 0.01 (100.00%)

DFR Gold

MCap

CAD16m

Last close

CAD0.10

▲ 0.03 (42.86%)

Context Therapeutics

MCap

USD17m

Last close

USD1.06

▲ 0.19 (21.84%)
Sectors
Sectors
Investment Strategy
Investment Strategy
View All

Latest
Thematics
Thematics
View All Thematics

Latest

Events
About Edison
About Edison
About Edison

Careers

“Edison’s accessible and high-quality research gives us the opportunity to communicate an independent perspective of Tyman to a wide variety of potential stakeholders.”

James Brotherton Financial Director — Tyman
Equity Research
Investor Relations
Contact us

Healthcare Equities

The companies that provide, support or coordinate medical goods and services. This sector spans a broad range of activities – including the development and manufacture of medical equipment, pharmaceuticals and other treatments. Activities range from research to manufacturing, administration, insurance and facilities management. Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals and specialty pharmaceuticals.

Sareum Holdings (SAR)

Latest price

GBP1.23

— 0.00 (0.00)

As at 02/06/2023

Market capitalisation: GBP83m

Scandion Oncology (SCOL)

Latest price

SEK1.49

▾ 0.04 (2.76)

As at 02/06/2023

Market capitalisation: SEK59m

03.04.23

Scandion Oncology — PANTAX Phase I trial meets primary endpoint

11.10.22

Scandion Oncology — CORIST part 3 begins enrolment

Healthcare

05.10.22

Scandion Oncology — Proof-of-concept data elusive

See more
content on

Scandion Oncology

Sequana Medical (SEQUA)

Latest price

EUR3.22

▾ −0.08 (−2.42)

As at 02/06/2023

Market capitalisation: EUR84m

25.10.22

Sequana Medical — POSEIDON pivotal study meets primary endpoint

Healthcare

12.09.22

Sequana Medical — Approaching key inflection points

Healthcare

15.08.22

Sequana Medical — DSR 2.0 moving forward

See more
content on

Sequana Medical

Shield Therapeutics (STX)

Latest price

GBP0.07

▾ 0.30 (4.65)

As at 02/06/2023

Market capitalisation: GBP48m

Healthcare

08.09.22

Shield Therapeutics — Tangible progress in US Accrufer launch

Healthcare

22.07.22

Shield Therapeutics — Focus on increasing US market access

Healthcare

01.07.22

Shield Therapeutics — Operating results eclipsed by financing difficulties

See more
content on

Shield Therapeutics

SIGA Technologies (SIGA)

Latest price

USD5.48

▾ −0.13 (−2.32)

As at 02/06/2023

Market capitalisation: USD391m

14.10.22

SIGA Technologies — TPOXX trials launched in treating monkeypox

Healthcare

03.10.22

SIGA Technologies — Second contract win from the US DoD in 2022

Healthcare

27.09.22

SIGA Technologies — Monkeypox concern drives international TPOXX win

See more
content on

SIGA Technologies

Ultimovacs (ULTI)

Latest price

NOK122.20

▾ 2.20 (1.83)

As at 02/06/2023

Market capitalisation: NOK4,203m

25.10.22

Ultimovacs — First patient in Phase II LUNGVAC study

18.10.22

Ultimovacs — Biomarker insight into UV1 combination

06.10.22

Ultimovacs — UV1 encouraging three-year survival data

See more
content on

VolitionRx (VNRX)

Latest price

USD1.48

▾ −0.07 (−4.52)

As at 02/06/2023

Market capitalisation: USD94m

volition01

Healthcare

15.08.22

VolitionRX — Unravelling the web of NETs in sepsis

Healthcare

28.02.20

VolitionRx — New platform format; more proof-of-concept data

Healthcare

22.11.19

VolitionRx — Data with product-grade assays expected soon

See more
content on

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free